Versor Investments LP Invests $787,000 in Oscar Health, Inc. (NYSE:OSCR)

Versor Investments LP acquired a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 37,100 shares of the company's stock, valued at approximately $787,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Point72 Hong Kong Ltd bought a new position in shares of Oscar Health in the 2nd quarter valued at about $78,000. Quest Partners LLC acquired a new position in Oscar Health during the second quarter valued at approximately $93,000. Amalgamated Bank grew its stake in Oscar Health by 27.7% in the second quarter. Amalgamated Bank now owns 6,727 shares of the company's stock valued at $106,000 after purchasing an additional 1,458 shares in the last quarter. Optimum Investment Advisors acquired a new position in shares of Oscar Health during the 3rd quarter worth approximately $142,000. Finally, Farallon Capital Management LLC bought a new stake in shares of Oscar Health during the 1st quarter worth approximately $164,000. 75.70% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts recently weighed in on OSCR shares. Piper Sandler reissued an "overweight" rating and issued a $28.00 target price on shares of Oscar Health in a research note on Tuesday, September 10th. Bank of America lowered Oscar Health from a "neutral" rating to an "underperform" rating and dropped their price objective for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. Finally, UBS Group started coverage on Oscar Health in a research note on Monday, October 7th. They set a "neutral" rating and a $23.00 target price for the company. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Oscar Health has an average rating of "Moderate Buy" and an average target price of $22.93.

Insider Transactions at Oscar Health

In related news, EVP Alessandrea C. Quane sold 16,793 shares of the business's stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $17.06, for a total value of $286,488.58. Following the completion of the sale, the executive vice president now directly owns 392,607 shares in the company, valued at approximately $6,697,875.42. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. In other news, CFO Richard Scott Blackley sold 68,978 shares of the company's stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $1,240,914.22. Following the completion of the sale, the chief financial officer now owns 884,213 shares of the company's stock, valued at approximately $15,906,991.87. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Alessandrea C. Quane sold 16,793 shares of Oscar Health stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $17.06, for a total transaction of $286,488.58. Following the completion of the transaction, the executive vice president now directly owns 392,607 shares in the company, valued at $6,697,875.42. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 169,569 shares of company stock valued at $3,007,069. 25.11% of the stock is currently owned by company insiders.

Oscar Health Stock Up 4.5 %

NYSE:OSCR traded up $0.61 during mid-day trading on Wednesday, hitting $14.17. 1,857,814 shares of the stock were exchanged, compared to its average volume of 3,324,019. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.91 and a current ratio of 0.73. The firm's 50-day simple moving average is $18.36 and its 200 day simple moving average is $18.33. Oscar Health, Inc. has a fifty-two week low of $6.93 and a fifty-two week high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business had revenue of $2.42 billion during the quarter, compared to analyst estimates of $2.33 billion. During the same quarter last year, the company posted ($0.29) earnings per share. The company's revenue was up 68.3% on a year-over-year basis. Sell-side analysts forecast that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.